Properties
- Form
- tableti
- Dosage mg
- 40
- Pack
- 28
What is it?
Name: Ryeco Indications for use Ryeco is used to treat moderate to severe symptoms of uterine fibroids in adult women of reproductive age. Contraindications - Hypersensitivity to the active substance or to any of the excipients listed in the "Composition" section; - Venous thromboembolism, current or history (e.g., deep vein thrombosis, pulmonary embolism); - Arterial thromboembolic complications, current or history (e.g., myocardial infarction, cerebrovascular accident, ischemic heart disease); - Known thrombophilic disorders (e.g., protein C, protein S or antithrombin deficiency, or activated protein C resistance (APC resistance), including Factor V Leiden (see "Precautions"); - Known osteoporosis; - Headaches with focal neurological symptoms or migraine with aura (see "Precautions"); - Known or suspected steroid hormone-sensitive malignant neoplasms (e.g., genital or breast malignancies); - Liver tumors (benign or malignant), current or history (see "Precautions"); - Severe liver diseases, current or history, until liver function tests normalize; - Known or suspected pregnancy and lactation (see "Use in pregnancy and lactation"); - Genital bleeding of unknown etiology; - Concomitant use of hormonal contraceptives. Dosage and administration Dosage regimen One tablet of Ryeco® should be taken once daily at approximately the same time, regardless of food intake. If necessary, tablets should be taken with a small amount of liquid (see "Pharmacokinetics"). In patients with risk factors for bone loss or osteoporosis, dual-energy X-ray absorptiometry (DXA) is recommended before starting treatment with Ryeco® (see "Precautions"). At the beginning of treatment, the first tablet should be taken within 5 days of the onset of menstrual bleeding. If treatment is initiated on another day of the menstrual cycle, irregular and/or heavy bleeding may occur initially. Pregnancy must be excluded before starting treatment with Ryeco®. Ryeco® can be taken continuously. The issue of discontinuing the drug should be considered at the onset of menopause, as uterine fibroids are known to regress after menopause. After 1 year of treatment, a DXA scan is recommended (see "Precautions"). Method of administration For oral use. Ryeco® can be taken regardless of food intake; if necessary, tablets should be taken with a small amount of liquid. Storage conditions The medicinal product does not require special storage conditions. Keep out of reach of children. Shelf life 3 years. Do not use after the expiry date indicated on the packaging.